Drug Trial Radar · NCT07598396
A Study to Evaluate Mosunetuzumab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis
Last checked: Nov 20, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
30
Planned (sponsor's estimate)
Start
May 25, 2026
Primary completion
Aug 11, 2028
Study completion Aug 11, 2028
Sponsor
- Lead sponsor
- Hoffmann-La RocheRoche (Genentech) (RHHBY)
- Sponsor type
- Industry
- First posted
- May 20, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will assess how mosunetuzumab works in people who have systemic lupus erythematosus (SLE) who may or may not also have active lupus nephritis (LN).
Conditions
- Lupus
- Systemic Lupus Erythematosus
- Lupus Nephritis
Interventions
MosunetuzumabDrug
Participants will receive SC mosunetuzumab.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of participants who have achieved remission by Week 76Time frame: Up to Week 76
Locations
24 sites in 6 countries. Site status is shown where the registry gives one.
Organizacion Medica de Investigacion (OMI)
CABA, Buenos Aires, Argentina · Recruiting
APRILLUS Asistencia e Investigacion
Buenos Aires, Ciudad Autonoma Buenos Aires, Argentina · Recruiting
Clnica SER da Bahia
Salvador, Estado de Bahia, Brazil · Recruiting
L2IP ?Instituto de Pesquisas Clínicas Ltda.
Brasília, Federal District, Brazil · Recruiting
IPC MT Instituto de Pesquisas Clinicas do Mato Grosso
Cuiab, Mato Grosso, Brazil · Recruiting
Complexo Hospitalar de Niteroi
Niterói, Rio de Janeiro, Brazil · Recruiting
LMK Servios Mdicos S/S Ltda
Porto Alegre, Rio Grande do Sul, Brazil · Recruiting
Hospital das Clinicas de Ribeirao Preto
Ribeiro Preto, São Paulo, Brazil · Recruiting
Hospital das Clnicas da Faculdade de Medicina da USP
São Paulo, São Paulo, Brazil · Recruiting
Clinica de la Costa S.A.S
Barranquilla, Colombia · Recruiting
Administradora Country S.A.S.
Bogotá, Colombia · Recruiting
Centro de Investigacion en Reumatologia y Especialdades Medicas SAS. CIREEM
Bogotá, Colombia · Recruiting
Hospital Pablo Tobon Uribe
Medellín, Colombia · Recruiting
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Rome, Lazio, Italy · Recruiting
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (Presidio Spedali Civili)
Brescia, Lombardy, Italy · Recruiting
Istituto Clinico Humanitas
Rozzano, Lombardy, Italy · Recruiting
CIMAB S.A. de C.V.
Torreón, Coahuila, Mexico · Recruiting
Centro Medico del Angel
Mexicali, Estado de Baja California, Mexico · Recruiting
CREA de Guadalajara, S.C.
Guadalajara, Jalisco, Mexico · Recruiting
Centro de Investigación y Tratamiento Reumatológico S.C.
México, Mexico CITY (federal District), Mexico · Recruiting
Centro de Investigación de Tratamientos Innovadores de Sinaloa (CITI)
Culiacán, Sinaloa, Mexico · Recruiting
Emmed Research
Pretoria, Gauteng, South Africa · Recruiting
University of Cape Town Kidney and Hypertension Research Unit
Cape Town, Western Cape, South Africa · Recruiting
Clinical Trials Network Helderberg
Somerset West, Western Cape, South Africa · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.